Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Hadden, US
David M. Hadden, Los Altos, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090180280 | MULTI-ACTION, BATTERY-POWERED, TRIGGER-ACTIVATED LIGHTING SYSTEM - A multi-action, battery-powered, trigger-activated lighting system automatically provides soft light upon human motion during the night, even in the event of a power outage, and can additionally be deployed quickly for use as an intense flashlight. Furthermore, it can provide low-battery indication to prompt the user to install fresh batteries whenever necessary, before a critical need arises. | 07-16-2009 |
Jeffrey A. Hadden, Worthington, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20090326688 | Systems and Methods for Fitting Golfers with Golf Clubs - Golf club fitting systems and methods include: (a) receiving input data indicating a golfer's driver loft angle and shaft flexibility characteristic; (b) determining initial candidate fairway wood clubs based on this data; and (c) identifying the initial candidate fairway wood clubs. Such systems and methods further may include: (d) receiving launch monitor data generated when the golfer hits balls using the initial candidate fairway wood clubs; (e) determining and identifying additional candidate fairway wood clubs for testing; (f) receiving launch monitor data generated when the golfer hits balls using the additional candidate fairway wood clubs; and (g) determining and identifying a recommendation for a final first fairway wood club based on the data. Other clubs in the fitted set also may be determined by these fitting systems and methods. | 12-31-2009 |
| 20100216563 | SYSTEM FOR DETERMINING PERFORMANCE CHARACTERISTICS OF A GOLF SWING - An instrumented golf club system and methods are disclosed. A variety of golf swing parameters are measured by the instrumented golf club and wirelessly transmitted to a portable computer device. The portable computer device generates a user interface that displays the golf swing parameters against preferred golf swing parameters. The instrumented golf club system allows a golfer to receive feedback in real time while playing golf. | 08-26-2010 |
| 20100216564 | SYSTEM FOR DETERMINING PERFORMANCE CHARACTERISTICS OF A GOLF SWING - An instrumented golf club system and methods are disclosed. A variety of golf swing parameters are measured by the instrumented golf club and wirelessly transmitted to a portable computer device. The portable computer device generates a user interface that displays the golf swing parameters against preferred golf swing parameters. The instrumented golf club system allows a golfer to receive feedback in real time while playing golf. | 08-26-2010 |
| 20100216565 | SYSTEM FOR DETERMINING PERFORMANCE CHARACTERISTICS OF A GOLF SWING - An instrumented golf club system and methods are disclosed. A variety of golf swing parameters are measured by the instrumented golf club and wirelessly transmitted to a portable computer device. The portable computer device generates a user interface that displays the golf swing parameters against preferred golf swing parameters. The instrumented golf club system allows a golfer to receive feedback in real time while playing golf | 08-26-2010 |
Jeffrey Alan Hadden, Worthington, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20110053698 | GOLF CLUBS AND GOLF CLUB HEADS HAVING DIGITAL LIE AND/OR OTHER ANGLE MEASURING EQUIPMENT - Golf club heads having sensors configured to measure one or more swing parameters are provided. The golf club head may include several gyroscopes and accelerometers. In one embodiment, the club head contains three gyroscopes that measure angular rate data along different orthogonal axes. At least one gyroscope may an analog gyroscope. Accelerometers may provide data regarding the three orthogonal axes associated with the gyroscopes. The club head may further include software and/or hardware that perform computer-executed methods for determining one or more swing parameters. Exemplary club heads may include a display device for displaying an output of the swing parameter(s). Further aspects of the invention relate to novel methods and algorithms for calculating measurements relating to the swing parameters. | 03-03-2011 |
Jeremy Hadden, Ketchum, ID US
| Patent application number | Description | Published |
|---|---|---|
| 20110007262 | EYEGLASS WITH ENHANCED BALLISTIC RESISTANCE - An eyeglass is provided that can comprise a frame, a lens, and at least one retention component that can secure the lens relative to the frame. The frame can be configured to support at least one lens in a field of view of a wearer. The frame can include a first ear stem and a second ear stem that allows the frame to be worn on the wearer's head. The at least one retention component can be supported by the frame and/or the lens and can be movable or fixed relative to the frame and/or the lens. The retention component can engage an engagement portion of the frame and/or the lens for preventing the lens from separating from the frame in response to a ballistic event. | 01-13-2011 |
John W. Hadden, Cold Spring Harbor, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090155291 | METHOD OF INCREASING IMMUNOLOGICAL EFFECT - A method of increasing immunological effect in a patient by administering an effective amount of a primary cell derived biologic to the patient, inducing immune production, blocking immune destruction, and increasing immunological effect in the patient. Methods of treating an immune target, treating a tumor, immune prophylaxis, and preventing tumor escape. | 06-18-2009 |
| 20100047182 | IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS - A diagnostic skin test for predicting treatment outcome, consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A kit for performing a skin test consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A method of performing a skin test on a patient, consisting essentially of the steps of administering an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the skin test, and predicting a treatment outcome. Methods of detecting defects in monocyte or T lymphocyte function, including the steps of administering an effective amount of an NCM or T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the skin test, and detecting at least one defect in monocyte or T lymphocyte function. A mechanism for indicating a functioning efferent or afferent limb of an immune system, including a diagnostic skin test including an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. | 02-25-2010 |
| 20100047205 | VACCINE IMMUNOTHERAPY - The present invention provides compositions and methods of immunotherapy to treat cancer or other antigen-producing diseases or lesions. According to one embodiment of the invention, a composition is provided for eliciting an immune response to at (east one antigen in a patient having an antigen-producing disease or lesion, the composition comprising an effective amount of a cytokine mixture, preferably comprising IL-1, IL-2, IL-6, IL-8, IFN-γ (gamma) and TNF-α (alpha). The cytokine mixture acts as an adjuvant with the antigen associated with the antigen-producing disease or lesion to enhance the immune response of the patient to the antigen. Methods are therefore also provided for eliciting an immune response to at least one antigen in a patient having an antigen-producing disease or lesion utilizing the cytokine mixture of the invention. The compositions and methods are useful in the treatment of antigen-producing diseases such as cancer, infectious diseases or persistent lesions. | 02-25-2010 |
| 20110044941 | IMMUNOTHERAPY FOR REVERSING IMMUNE SUPPRESSION - A method for overcoming immune suppression includes the steps of inducing production of naïve T cells and restoring T cell immunity. A method of vaccine immunotherapy includes the steps of inducing production of naïve T cells and exposing the naïve T cells to endogenous or exogenous antigens at an appropriate site. Additionally, a method for unblocking immunization at a regional lymph node includes the steps of promoting differentiation and maturation of immature dendritic cells at a regional lymph node and allowing presentation of processed peptides by resulting mature dendritic cells, thus, for example, exposing tumor peptides to T cells to gain immunization of the T cells. Further, a method of treating cancer and other persistent lesions includes the steps of administering an effective amount of a natural cytokine mixture as an adjuvant to endogenous or exogenous administered antigen to the cancer or other persistent lesions; preferably the natural cytokine mixture is administered in combination with thymosin α | 02-24-2011 |
| 20110076249 | IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS - The present invention provides compositions of a natural cytokine mixture (NCM) for treating a cellular immunodeficiency characterized by T lymphocytopenia, one or more dendritic cell functional defects such as those associated with lymph node sinus histiocytosis, and/or one or more monocyte functional defects such as those associated with a negative skin test to NCM. The invention includes methods of treating these cellular immunodeficiencies using the NCM of the invention. The compositions and methods are useful in the treatment of diseases associated with cellular immunodeficiencies such as cancer. Also provided are compositions and methods for reversing tumor-induced immune suppression comprising a chemical inhibitor and a non-steroidal anti-inflammatory drug (NSAID). The invention also provides a diagnostic skin test comprising NCM for predicting treatment outcome in cancer patients. | 03-31-2011 |
| 20110081313 | MECHANISM OF ACTION OF PRIMARY CELL DERIVED BIOLOGIC - A method of treating an immune target that is suppressing the immune system and restoring the immune system, including the steps of administering an effective amount of a primary cell derived biologic, modifying populations of B and T cells in blood, activating regional lymph nodes, infiltrating an area adjacent to an immune target with T helper and B cells, infiltrating the immune target with T killer cells and macrophages, and treating the immune target and restoring the immune system. A method of inducing immunization in a patient. A method of destroying a tumor. A method of predicting a favorable treatment outcome to cancer treatment. A method of immune prophylaxis. A method of immune restoration. A method of treating a tumor. A method of preventing tumor escape. | 04-07-2011 |
| 20110110884 | IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS - The present invention provides compositions of a natural cytokine mixture (NCM) for treating a cellular immunodeficiency characterized by T lymphocytopenia, one or more dendritic cell functional defects such as those associated with lymph node sinus histiocytosis, and/or one or more monocyte functional defects such as those associated with a negative skin test to NCM. The invention includes methods of treating these cellular immunodeficiencies using the NCM of the invention. The compositions and methods are useful in the treatment of diseases associated with cellular immunodeficiencies such as cancer. Also provided are compositions and methods for reversing tumor-induced immune suppression comprising a chemical inhibitor and a non-steroidal anti-inflammatory drug (NSAID). The invention also provides a diagnostic skin test comprising NCM for predicting treatment outcome in cancer patients. | 05-12-2011 |
John W. Hadden, Spring Harbor, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100310469 | VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS - A method of immunotherapy to treat cancer or a synergistic anti-cancer treatment by administering an effective amount of natural cytokine mixture (NCM), an effective amount of cyclophosphamide (CY), or an effective amount of indomethacin (INDO), wherein the NCM, CY, or INDO are administered singly or in communications thereof. An anti-metastatic treatment method by promoting differentiation and maturation of immature dendritic cells in a lymph node; allowing presentation thereof; and preventing development of metastasis. A method of using NCM as a diagnostic skin test for predicting treatment outcome. A method of pre-treating dendritic cells (DC) and a method of treating monocyte defects characterized by sinus histiocytosis or a negative NCM skin test. Compositions and method for eliciting an immune response to endogenous or exogenous tumor antigens. | 12-09-2010 |
Michael Shane Hadden, Stamford, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20080243569 | AUTOMATED LOAN SYSTEM AND METHOD - The invention provides an automated system and method for providing a loan to a consumer. A loan request is received from a borrower. In response to receiving the loan request, non loan revenue associated with the borrower is determined. At least one loan term for a loan for the borrower is determined, based, at least in part, upon the non loan revenue. The method is carried out by analyzing information related to consumer purchases associated with the borrower. An amount of non loan revenue to be associated with the borrower is based, at least in part, on the information about consumer purchases. | 10-02-2008 |
Page Hadden, San Rafael, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090212081 | SLOSH CONTROLLED PERSONAL HYDRATION SYSTEM - The present invention relates to a personal hydration system. In one exemplary embodiment, the personal hydration system may comprise a hydration reservoir for containing a supply of hydrating fluid, the hydration reservoir may comprise a plurality of compartments. The hydration reservoir may have a low profile and may comprise at least one baffle. | 08-27-2009 |
Robert W. Hadden, Highland Village, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20100180418 | Synthetic Redundancy Via Prognostics - An manufacturing method that uses synthetic redundancy to optimize equipment reliability, performance, weight, and cost. The manufacturing method identifies critical components, that would ordinarily require a redundant component to meet reliability and safety requirements, and replaces them with a single, non-redundant component. Safety and reliability is maintained by using prognostic health management to replace the non-redundant critical component prior to its failure. Verification techniques are used to ensure reliability requirements are being met. | 07-22-2010 |
Shane Hadden, Greenwich, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20090192829 | Variable product reinsurance - A Variable Product reinsurance structure including: (i) a reinsurance Agreement between a Variable Product issuer (Ceding Company), and a separate account or Cell of a reinsurer, qualifying for (re)insurance accounting under FAS 133; and (ii) a plurality of derivative instruments qualifying for mark-to-market accounting under FAS 133, designed to hedge exposure to an index of securities that correlates to the specific market risks assumed by the Cell under the Agreement (hedges), purchased for the account of the Cell from multiple dealers, wherein none of the hedge dealers retains more than 50% of the risk of loss. The structure may also include (A) a basis hedge purchased from a third party dealer to hedge other risks assumed by the Cell or (B)(1) a note issued by the Cell, (2) an assumption by the Ceding Company of the risk of non-payment by the hedge dealers and, (3) a contract with an intermediary. | 07-30-2009 |
Steve L. Hadden, Peoria, AZ US
| Patent application number | Description | Published |
|---|---|---|
| 20090027148 | BI-STABLE MAGNETIC LATCH WITH PERMANENT MAGNET STATOR - A magnetic latch includes a stator having first and second permanent magnets disposed on either side of a center portion. Each of the first and second permanent magnets has at least two associated poles. A rotor has at least one magnetic region. The rotor is configured for rotation about an axis of the stator between a first latched position and a second latched position. | 01-29-2009 |
Steven Hadden, Peoria, AZ US
| Patent application number | Description | Published |
|---|---|---|
| 20090243169 | SYSTEMS FOR DAMPING VIBRATIONS FROM A PAYLOAD - Systems are provided for damping vibrations from a payload. In an embodiment, and by way of example only, the system includes an isolation strut and a gas line. The isolation strut includes a bellows and a piston. The bellows has a first end and a second end, the first end being enclosed, and the second end attached to the piston to define a chamber. The piston includes a damping annulus therethrough having a gas inlet and a gas outlet. The gas inlet provides flow communication to the chamber of the bellows. The gas line is coupled to the isolation strut and is in fluid communication with the gas outlet thereof. The system is hermetically sealed to contain a gas therein. | 10-01-2009 |